Soleno Therapeutics, Inc.
SLNO
$33.39
-$0.37-1.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.36M | 26.01M | -4.71M | -43.77M | -55.98M |
| Total Depreciation and Amortization | 509.00K | 502.00K | 502.00K | 504.00K | 503.00K |
| Total Amortization of Deferred Charges | 9.00K | 9.00K | 9.00K | 8.00K | -- |
| Total Other Non-Cash Items | 11.24M | 10.38M | 10.01M | 16.87M | 28.88M |
| Change in Net Operating Assets | -6.42M | 6.56M | -18.42M | -6.36M | 2.61M |
| Cash from Operations | 48.70M | 43.45M | -12.61M | -32.75M | -23.99M |
| Capital Expenditure | -58.00K | -1.00K | -9.00K | -5.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -125.30M | -91.44M | -7.91M | 22.94M | 6.45M |
| Cash from Investing | -125.36M | -91.44M | -7.92M | 22.94M | 6.44M |
| Total Debt Issued | -- | -- | -- | -- | 49.89M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 954.00K | 217.98M | 15.90M | 3.28M | 7.18M |
| Repurchase of Common Stock | -100.85M | 0.00 | -33.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 178.00K | -178.00K | -62.00K | -- |
| Cash from Financing | -99.90M | 218.15M | 15.69M | 3.22M | 57.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.56M | 170.17M | -4.83M | -6.60M | 39.52M |